Overview
The Orphanet entry 'Anomaly of chromosome 17' (Orphanet code 261748) is an obsolete classification that was previously used as a broad grouping term for chromosomal abnormalities involving chromosome 17. This entry has been retired from active use in the Orphanet classification system, meaning it no longer serves as a current diagnostic or reference category. Chromosome 17 abnormalities encompass a wide range of structural and numerical changes — including deletions, duplications, translocations, and other rearrangements — each of which has been reclassified into more specific disease entities with distinct clinical presentations. Examples of well-characterized conditions involving chromosome 17 include Smith-Magenis syndrome (17p11.2 deletion), Miller-Dieker lissencephaly syndrome (17p13.3 deletion), Charcot-Marie-Tooth disease type 1A (17p12 duplication), and Potocki-Lupski syndrome (17p11.2 duplication), among others. Because this is an obsolete umbrella term rather than a specific clinical entity, there are no defined symptoms, inheritance patterns, or treatments associated with this particular code. Patients and clinicians seeking information about a chromosome 17 abnormality should refer to the specific condition diagnosed through cytogenetic or molecular testing for accurate clinical guidance.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Anomaly of chromosome 17.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Anomaly of chromosome 17 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Anomaly of chromosome 17.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Anomaly of chromosome 17.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Anomaly of chromosome 17.
Start the conversation →Latest news about OBSOLETE: Anomaly of chromosome 17
No recent news articles for OBSOLETE: Anomaly of chromosome 17.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Anomaly of chromosome 17
What is OBSOLETE: Anomaly of chromosome 17?
The Orphanet entry 'Anomaly of chromosome 17' (Orphanet code 261748) is an obsolete classification that was previously used as a broad grouping term for chromosomal abnormalities involving chromosome 17. This entry has been retired from active use in the Orphanet classification system, meaning it no longer serves as a current diagnostic or reference category. Chromosome 17 abnormalities encompass a wide range of structural and numerical changes — including deletions, duplications, translocations, and other rearrangements — each of which has been reclassified into more specific disease entities